BPAVX
Price
$31.60
Change
+$0.37 (+1.18%)
Updated
Jun 6 closing price
Net Assets
1.3B
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

BPAVX vs VIVAX

Header iconBPAVX vs VIVAX Comparison
Open Charts BPAVX vs VIVAXBanner chart's image
Boston Partners All Cap Value I
Price$31.60
Change+$0.37 (+1.18%)
VolumeN/A
Net Assets1.3B
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
BPAVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BPAVX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPAVX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. BPAVX (1.31B). VIVAX pays higher dividends than BPAVX: VIVAX (2.16) vs BPAVX (0.64). BPAVX was incepted earlier than VIVAX: BPAVX (23 years) vs VIVAX (33 years). BPAVX (1.10) is less costly to investors than VIVAX (0.17). BPAVX is a more actively managed with annual turnover of: 24.00 vs. VIVAX (9.00). BPAVX has a lower initial minimum investment than VIVAX: BPAVX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. BPAVX (-0.54). VIVAX return over 5 years is better than : 58.70 vs. BPAVX (31.81).
BPAVXVIVAXBPAVX / VIVAX
Total Expense Ratio1.050.17618%
Annual Report Gross Expense Ratio1.100.17647%
Fund Existence23 years33 years-
Gain YTD3.9961.238323%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B189B1%
Annual Yield % from dividends0.642.1630%
Returns for 1 year-0.546.81-8%
Returns for 3 years-2.8318.51-15%
Returns for 5 years31.8158.7054%
Returns for 10 years44.12102.9043%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc